Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Front Surg ; 7: 533567, 2020.
Article in English | MEDLINE | ID: mdl-33195384

ABSTRACT

Non-missile transorbital penetrating head injuries are relatively rare, though potentially fatal injuries. Trajectory for intracranial entrance is typically via the orbital roof, the superior orbital fissure (SOF), or the optic canal. Non-metallic intracranial penetrating injuries are even scarcer and may pose unusual diagnostic and surgical challenges. Here we present and discuss a unique case of a penetrating injury by a wooden foreign body (FB) which entered and expanded the inter-dural space of the lateral cavernous sinus (CS) sinus wall without intracavernous or intradural involvement. The patient was a 71 year-old male who fell face-down and sustained a penetrating transorbital injury by a dry twig fragment, which passed through the SOF and into the interdural space of lateral wall of the ipsilateral CS. The patient was fully conscious (GCS15) at presentation but had severe ocular injury (complete ophthalmoplegia and blindness of the injured eye). The wooden FB was successfully removed via a minimally invasive subtemporal intradural approach with no apparent immediate or long-term complications. We emphasize the unusual diagnostic and surgical challenges related to this kind of rare injuries as reflected by the decision-making considerations taken in the presented case.

2.
Isr Med Assoc J ; 19(9): 538-542, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28971635

ABSTRACT

BACKGROUND: Little is known about the incidence of urinary tract infections (UTI) in the dispersed Bedouin population. UTIs are routinely treated empirically according to local resistance patterns, which is important when evaluating the risk factors and antibiotic resistance patterns in the Bedouin population. OBJECTIVES: To analyze risk factors, pathogens, and antibiotic resistance patterns of UTIs in the Bedouin population compared to the general population in southern Israel. To compare data from this study to that from a previous study conducted at our center. METHODS: We prospectively followed all patients hospitalized with community acquired UTIs during a 4 month period at Soroka Medical Center. We also compared results from this study to those from a study conducted in 2000. RESULTS: The study comprised 223 patients: 44 Bedouin (19.7%), 179 (80.3) non-Bedouin; 158 female (70.9%), 65 male (29.1). The Bedouin were younger (51.7 vs. 71.1 years of age, P < 0.001) and had a lower Charlson Comorbidity Index (2.25 vs. 4.87, P < 0.001). Enterobacteriaceae were the most common pathogens identified, and Escherichia coli (E. coli) was the most common with 156 (70%) strains identified, followed by Klebsiella spp. with 29 (13%), Proteus spp. with 18 (8%), pseudomonas with 9 (4%), and other bacteria including enterococci with 11 (5%). The prevalence of E. coli increased significantly from 56% in 2000 to 70% in this study. We also noted an increase in community acquired extended spectrum beta lactamase (ESBL) pathogens from 4.5% in 2000 to 25.5% in the present study. No statistically significant difference was observed between the Bedouin and general populations in the causal pathogens, resistance to antibiotics, length of therapy, and readmission rate within 60 days. CONCLUSIONS: The Bedouin population hospitalized for UTIs is younger and presents with fewer co-morbidities. Isolated pathogens were similar to those found in the general population as was the presence of drug resistant infections. Overall, a substantial percentage of pathogens were resistant to standard first-line antibiotics, driving the need to change from empiric therapy to aminoglycoside therapy.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Urinary Tract Infections/drug therapy , Arabs , Community-Acquired Infections/drug therapy , Community-Acquired Infections/ethnology , Escherichia coli , Escherichia coli Infections/drug therapy , Escherichia coli Infections/ethnology , Female , Humans , Israel/ethnology , Male , Prospective Studies , Urinary Tract Infections/ethnology
3.
Travel Med Infect Dis ; 9(6): 303-5, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22037052

ABSTRACT

In Israel, a malaria-free country, we have noticed lately an increase of hospital admissions with malaria, parallel to the rise in the number of Eritrean and Sudanese migrants. Eritrea and Sudan are malaria-endemic countries; Plasmodium falciparum accounts for 85-90% and Plasmodium vivax accounts for 10-15% of malaria species in these areas. We aimed to describe the features of malaria in this migrant population by conducting a retrospective descriptive study of Eritrean and Sudanese migrants admitted with malaria during 1/2009-4/2010. Patient files were reviewed for demographics, clinical data, laboratory tests, treatment and outcome. 101 patients (mean age 24.9 (SD 5.6) years; 86.1% males) with malaria were identified. 87.1% were infected with P. vivax, 6% with P. falciparum, and 6.9% had both. All presented with pyrexia. None had respiratory or cerebral complications. Mean length of hospitalization was 2.49 (SD 1.5) days. No treatment failures or complications were observed. We conclude that in countries with waves of migrants from malaria-endemic areas, onset of fever should raise suspicion of malaria. Contrary to the known dominance of P. falciparum among malaria species in Eritrea and Sudan, the vast majority of migrants presented with P. vivax. The region of P. vivax acquisition remains unclear.


Subject(s)
Antimalarials/administration & dosage , Malaria, Falciparum/ethnology , Malaria, Vivax/ethnology , Plasmodium falciparum/immunology , Plasmodium vivax/immunology , Transients and Migrants , Adult , Antigens, Protozoan , Chloroquine/administration & dosage , Eritrea/ethnology , Female , Hospitalization , Humans , Israel/epidemiology , Malaria, Falciparum/drug therapy , Malaria, Vivax/drug therapy , Male , Mefloquine/administration & dosage , Plasmodium falciparum/isolation & purification , Plasmodium vivax/isolation & purification , Population Surveillance , Retrospective Studies , Sudan/ethnology , Treatment Outcome , Young Adult
4.
Int J Infect Dis ; 15(7): e470-4, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21601504

ABSTRACT

OBJECTIVES: To determine the risk factors for community-acquired pneumonia (CAP) with influenza A/H1N1 flu in our region. METHODS: Adult patients with CAP from July 2009 to February 2010 who were screened for influenza A/H1N1 were identified retrospectively. This was a retrospective case-control study. Cases had CAP with influenza A/H1N1 and controls had CAP without influenza A/H1N1. Patient files were reviewed for demographics, clinical characteristics, treatment, and outcome. RESULTS: Three hundred and eight patients with CAP were identified: 107 cases and 201 controls. For cases vs. controls there were significant differences in the following: median age (40 (range 18-82) vs. 56 (range 18-89) years; p<0.001), female gender (63.6% vs. 44.3%; p<0.05), Bedouin Arab origin (41.1% vs. 26.4%; p<0.05), pyrexia (97.6% vs. 88.5%; p<0.01), cough (96.3% vs. 75%; p<0.05), admission to the intensive care unit (18.7% vs. 10.6%; p<0.05), and CURB-65 score ≥ 3 (2.8% vs. 11.4%; p<0.05). Laboratory values including white blood cell (WBC) and platelet counts were lower in cases than in controls, whereas creatine phosphokinase and lactate dehydrogenase levels were higher (p<0.01). By logistic regression models, young age, Bedouin origin, and lower WBC and platelet counts were independent risk factors for the acquisition of CAP with influenza A/H1N1. CONCLUSIONS: In our region CAP with influenza A/H1N1 occurred in younger females of Bedouin Arab origin with less co-morbidity. No difference in mortality was found. We believe that inequalities in socioeconomic conditions could explain our findings.


Subject(s)
Community-Acquired Infections/complications , Influenza, Human/complications , Pneumonia, Bacterial/complications , Pneumonia/complications , Adolescent , Adult , Aged , Arabs , Case-Control Studies , Community-Acquired Infections/epidemiology , Community-Acquired Infections/ethnology , Community-Acquired Infections/microbiology , Female , Humans , Influenza A Virus, H1N1 Subtype , Influenza, Human/epidemiology , Influenza, Human/ethnology , Influenza, Human/virology , Israel/epidemiology , Israel/ethnology , Male , Middle Aged , Pneumonia/ethnology , Pneumonia/microbiology , Pneumonia, Bacterial/ethnology , Pneumonia, Bacterial/microbiology , Risk Factors , Young Adult
5.
Am J Med Sci ; 337(6): 466-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19359983

ABSTRACT

Autoimmune hepatitis (AIH) is a progressive, chronic disease of unknown cause with varying presenting symptoms, ranging from no symptoms through nonspecific symptoms to fulminant hepatic failure. Although nonspecific hematologic abnormalities in AIH may occur, a case of agranulocytosis (<100 neutrophils/microL) associated with a flare of AIH and suspected to be of autoimmune origin was recently reported. Increased levels of suppressing cytokines had been previously reported in bone marrow samples of patients with AIH type-1 (AIH-1). These changes could be related to induction of apoptosis or interference with differentiation and proliferation of the myeloid lineage, hence, playing a meaningful role in the pathogenesis of agranulocytosis in patients with AIH-1. Here, we report a patient with agranulocytosis at first presentation of AIH-1. On the basis of the patient's diagnostic evaluation, response to administered therapy, and the review of the literature, we suggest several possible mechanisms relating to bone marrow cytokine milieu changes, in addition to autoimmune pathogenesis, that could explain this phenomenon.


Subject(s)
Agranulocytosis/complications , Hepatitis, Autoimmune/complications , Agranulocytosis/drug therapy , Female , Granulocyte Colony-Stimulating Factor/therapeutic use , Hepatitis, Autoimmune/drug therapy , Humans , Middle Aged , Steroids/therapeutic use
6.
Microbes Infect ; 8(7): 1801-5, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16822690

ABSTRACT

Staphylococcus aureus is an important cause of skin infections. We recently described an outbreak of recurrent furunculosis involving methicillin-resistant S. aureus among mentally retarded adults. We sought to determine the role of impaired neutrophil functions in its pathogenesis. Blood neutrophil functions were determined during both the outbreak (1997) and a disease-free period (2000). Chemotaxis was measured by migration toward formyl-methionyl-leucyl-phenylalanine (FMLP), specifically and randomly; phagocytosis of opsonized zymosan (OZ) was assessed by microscopy; superoxide production was determined by cytochrome c reduction in unstimulated neutrophils and after stimulation with 50 ng/ml phorbol myristate acetate, 1 mg/ml OZ or 5 x 10(-7)M FMLP. Functions were compared between recurrent furunculosis (n=10) and non-recurrent furunculosis patients (n=13). During 2000, functions were normal among the 23 subjects, except for specific/nonspecific chemotaxis (mean 68%+/-26 and 69%+/-28). During infection, recurrent furunculosis patients had a significantly increased basal superoxide production as compared to disease-free period (10.5+/-4.7 vs. 4.9+/-1.9 nmol O(-)(2)/10(6) cells/min, p=0.003). During the disease-free period, recurrent furunculosis patients had lower basal superoxide production (4.9+/-1.9 vs. 7.7+/-3.5, p=0.067) and impaired specific chemotaxis (57%+/-28 vs. 76%+/-21, p<0.05) as compared to non-recurrent furunculosis patients. Only specific chemotaxis was an independent risk factor for recurrent furunculosis. Mentally retarded adults have impaired chemotaxis, with recurrent furunculosis cases having an even greater impairment. Abnormal specific chemotaxis is an independent risk factor for recurrent furunculosis. Impaired neutrophil functions thus have a role in the pathogenesis of outbreaks of recurrent furunculosis.


Subject(s)
Disease Outbreaks , Furunculosis/immunology , Intellectual Disability , Methicillin Resistance , Neutrophils/immunology , Residential Facilities , Staphylococcus aureus , Adult , Cell Movement , Chemotaxis, Leukocyte , Community-Acquired Infections/epidemiology , Community-Acquired Infections/immunology , Community-Acquired Infections/microbiology , Furunculosis/epidemiology , Furunculosis/microbiology , Humans , Neutrophils/metabolism , Neutrophils/physiology , Phagocytosis , Recurrence , Staphylococcus aureus/drug effects , Superoxides/analysis , Superoxides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...